Invention Grant
- Patent Title: Method of treatment using stable liquid formulation of G-CSF
- Patent Title (中): 使用G-CSF稳定液体制剂的治疗方法
-
Application No.: US14044852Application Date: 2013-10-02
-
Publication No.: US08946161B2Publication Date: 2015-02-03
- Inventor: Walter Hinderer , Heinz Lubenau
- Applicant: Biogenerix GmbH
- Applicant Address: DE Ulm
- Assignee: Ratiopharm GmbH
- Current Assignee: Ratiopharm GmbH
- Current Assignee Address: DE Ulm
- Agency: MH2 Technology Law Group, LLP
- Priority: DE102007040932 20070827; EP07016763 20070827
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61P35/00 ; A61K47/02 ; A61K47/26 ; A61K9/00 ; A61K38/19 ; A61K47/12

Abstract:
Provided are pharmaceutical liquid formulations of G-CSF, which are stable over a long time period and substantially free of excipients, as well as ready-to-use syringes containing such formulations and corresponding kits.
Public/Granted literature
- US20140030214A1 LIQUID FORMULATION OF G-CSF Public/Granted day:2014-01-30
Information query
IPC分类: